news 2022



Results 21 - 28 of 28.

Health - Pharmacology - 04.02.2022
Four out of ten cancer survivors suffer from chronic pain
VUB research suggests pain education and lifestyle are important components of a multimodal approach to treat persistent pain Friday, February 4, 2022 — 4 February is #WorldCancerDay After cancer treatment, many patients continue to suffer from pain. About four out of ten cancer survivors have chronic pain complaints.

Health - Pharmacology - 02.02.2022
Amino acid proline key to promising new treatment strategy for myeloma patients
World Cancer Day, 4 February: Award-winning research on incurable blood cancer Researchers at the Vrije Universiteit Brussel, led by Eline Menu, have investigated how changes in metabolism contribute to cancer resistance and relapse.

Health - 01.02.2022
The eye as a window into heart disease
AI system can predict risk of heart attack based on retinal scan An international team of researchers have developed an AI system that can identify patients who are likely to have a heart attack over the next year. The system reads retinal scans that are already commonly used in eye clinics. Doctors have recognised that changes to the tiny blood vessels in the retina are indicators of broader vascular disease, including problems with the heart.

Health - Pharmacology - 01.02.2022
Predictive model should avoid need for surgery in rectal cancer
Two research groups from the Vrije Universiteit Brussel have established a collaboration in which they predict the response to the standard treatment for rectal cancer based on medical images (e.g.

Health - Pharmacology - 30.01.2022
Lactic acid weakens anti-tumour defences
In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defence against tumours.

Health - Life Sciences - 24.01.2022
Link between sugar metabolism and Parkinson's disease
Link between sugar metabolism and Parkinson’s disease
In brief: Parkinson's disease is the second most common neurodegenerative disease, but we still do not understand why this disease occurs. Scientists from the UCLouvain de Duve Institute have discovered a new type of molecular damage that is (glycolysis). They also discovered a mechanism that allows cells to prevent this type of damage.

Life Sciences - Health - 21.01.2022
Scientist receives grant for promising Alzheimer research
Researcher returns from US with state-of-the-art knowledge Friday, January 21, 2022 — VUB scientist Gamze Ates has been awarded 100,000 for research into Alzheimer's disease.

Health - Social Sciences - 12.01.2022
Water determines health, skeleton research shows
VUB research shows that living close to wetlands increases risk of diseases such as malaria or pulmonary infections such as possible Tuberculosis Wednesday, January 12, 2022 — For her PhD at the Vrije Universiteit Brussel and the University of Sheffield, Dr. Marit Van Cant studied medieval to early modern skeletal populations from six archaeological sites in Flanders.